** Shares of Genscript Biotech Corp 1548.HK jump 8.3% to HK$17.78, their highest since June 11
** Stock on course for the biggest one-day pct gain since June 9; fifth biggest pct gainer on healthcare index .HSCIH, which is up 0.5%
** The bioscience research group expects its H1 profit before tax to be in $175.4 mln-$204.6 mln range, as compared to $127.9 mln loss the same period a year ago, thanks to an increase in license revenue among others
** Hang Seng Biotech Index .HSHKBIO climbs 0.7%, Hang Seng Index .HSI gains 0.3%
** YTD, stock up 74.8%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.